About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
ecancer
ecancer.org
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ESMO GI 2024
Best of ASCO® 2024 Miami Symposium
ASCO® 2024
EHA 2024
ELCC 2024
EAU 2024
ASCO GU 2024
ASCO GI 2024
2023
AORTIC 2023
ASH 2023
SABCS 2023
ESMO 2023
WCLC 2023
ESMO WCGIC 2023
ASCO® 2023
EHA® 2023
ELCC 2023
ASCO GU 2023
BGICC 2023
ASCO GI 2023
2022 and 2021
SABCS 2022
ESMO 2022
WCLC 2022
EHA 2022
ASCO 2022
ASCO 2021
Common Sense Oncology
Lymphoma
Leukemia
Myeloma
GYN Cancers
Head&Neck Cancers
GI Cancers
Breast Cancers
GU Cancers
Lung Cancers
Skin Cancers
Basic Science
Supportive & Palliative Care
Business
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
L
ASCO® 2024 Insights: "HARMONi-A Study - Ivonescimab + Chemo for EGFRm NSCLC Patients Who Progressed on EGFR-TKI Treatment"
By
ecancer
FEATURING
Li Zhang
By
ecancer
FEATURING
Li Zhang
16 views
July 2, 2024
0 Comments
Login to view comments.
Click here to Login
Featured Video
11:42
ImmunoGen
Best Practices for the management of ocular adverse events associate…
Feat.
K. Lamoreau
Featured Video
19:51
AstraZeneca Oncology
Management Strategies for Fatigue and Asthenia in First-line Mainten…
Feat.
D. Czel,
C. Arn
ASCO® 2024
06:26
ecancer
Post-Transplant Cyclophosphamide Based GVHD Prophylaxis in Patients …
Feat.
M. Al Malki,
S. Devine
09:04
ecancer
ASCO® 2024 Insights: "Importance of MRD in Newly Diagnosed Mult…
Feat.
X. Leleu
40:00
ecancer
ASCO® 2024: Highlights and Analysis of Key Solid Cancer Trials
Feat.
B. Gyawali
04:26
ecancer
ASCO® 2024 Insights: "NRG-LU002 Trial - Maintenance vs. Local C…
Feat.
P. Iyengar
04:35
ecancer
ASCO® 2024 Insights: "Avelumab in Early TNBC With Residual Dise…
Feat.
P. Conte
05:26
ecancer
ASCO® 2024 Lung Cancer Updates: CROWN, ADRIATIC, and LAURA Trials
Feat.
L. Raez
03:04
ecancer
ASCO® 2024 Insights: "HARMONi-A Study - Ivonescimab + Chemo for…
Feat.
L. Zhang
02:48
ecancer
ASCO® 2024 Insights: "Clinical Behavior and Prognostic Impact o…
Feat.
M. Lambertini
04:11
ecancer
ASCO® 2024 Insights: "INAVO-PBO Trial - 1L Inavolisib/Placebo +…
Feat.
D. Juric
02:54
ecancer
ASCO® 2024 Insights: "MajesTEC-7 Study - Safety and Efficacy of…
Feat.
S. Manier
03:48
ecancer
ASCO® 2024 Insights: "Results of Preliminary Safety & Effic…
Feat.
N. Neparidze
03:48
ecancer
ASCO® 2024 Insights: "CARTITUDE-4 Study - Benefits of Ciltacabt…
Feat.
L. Costa
02:27
ecancer
ASCO® 2024 Insights: "Monitoring Ovarian Function in DeFi Study…
Feat.
E. Loggers
17:44
ecancer
ASCO® 2024 Summary: "Expert Panel Discussion on the Real World …
Feat.
F. Schlürmann,
B. Hadaschik,
K. Fizazi
22:22
ecancer
ASCO® 2024 Summary: "Expert Panel Discussion on Best Practices …
Feat.
M. Schostak,
A. Wyatt,
C. Ryan,
E. Antonarakis
04:40
ecancer
ASCO® 2024 Insights: "PERSEUS Trial - MRD Analysis of Dara + VR…
Feat.
P. Rodríguez-Otero
12:37
ecancer
ASCO® 2024 Summary: "IMROZ & BENEFIT Studies in Newly Diagn…
Feat.
X. Leleu
04:34
ecancer
ASCO® 2024 Insights: "IMROZ - A Ph3 Study of Isatuximab + VRd v…
Feat.
T. Facon
19:33
ecancer
ASCO® 2024 Lung Cancer Roundtable: Advances in NSCLC
Feat.
E. Felip,
A. Spira,
A. Passaro,
A. Addeo
04:33
ecancer
ASCO® 2024 Insights: "ADRIATIC Study - Durvalumab as Consolidat…
Feat.
D. Spigel
02:26
ecancer
ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxe…
Feat.
R. Jotte
02:57
ecancer
ASCO® 2024 Insights: "LAURA Study - Osimertinib After Definitiv…
Feat.
S. Ramalingam
05:00
ecancer
ASCO® 2024 Insights: "CARACO Trial - Omission of Lymphadenectom…
Feat.
J. Classe
06:37
ecancer
ASCO® 2024 Insights: "Final OS & PFS From the AGO-OVAR 2.29…
Feat.
F. Marmé
01:47
ecancer
ASCO® 2024 Insights: "Comparing Preoperative Chemo to Neoadjuva…
Feat.
J. Hoeppner
06:13
ecancer
ASCO® 2024 Insights: "BrUOG 354 Trial - Nivo Alone or in Combin…
Feat.
D. Dizon
04:01
ecancer
ASCO® 2024 Insights: "CHAARTED2 Trial - Cabazitaxel With Abirat…
Feat.
C. Kyriakopoulos
04:52
ecancer
ASCO® 2024 Insights: "Telehealth Palliative Care for Advanced L…
Feat.
J. Greer
05:00
ecancer
ASCO® 2024 Insights: "E3311 Trial - Enhancing Oropharynx Cancer…
Feat.
B. Burtness
04:07
ecancer
ASCO® 2024 Insights: "I-SPY2.2 Trial - Pathologic Response to N…
Feat.
J. Meisel
02:57
ecancer
ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi vs.…
Feat.
C. Blank
04:35
ecancer
ASCO® 2024 Insights: "SURE-01/02 Study - Perioperative Sacituzu…
Feat.
A. Cigliola
03:12
ecancer
ASCO® 2024 Insights: "PIVOTAL Study - Neoadjuvant Daromun vs. I…
Feat.
A. Hauschild
04:41
ecancer
ASCO® 2024 Insights: "PSMAfore - HRQoL and Pain in Taxane-Naïve…
Feat.
K. Fizazi
02:52
ecancer
ASCO® 2024 Insights: "Long-Term Follow-Up of MajesTEC-1 Trial -…
Feat.
A. Garfall
04:25
ecancer
ASCO® 2024 Insights: "Summary of the PASS-01 Trial - 1L FOLFIRI…
Feat.
J. Knox
